Dr. Douglas J. Van Putten, FACS, MD

Dr. Van Putten practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Van Putten's NPI, 1851378558, was assigned on December 23, 2005. Dr. Van Putten graduated from Loma Linda University School Of Medicine in 1985. Dr. Van Putten holds California license G58345.

Dr. Van Putten's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Van Putten's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Van Putten is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Van Putten to 1 more hospital, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Van Putten's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Putten practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Van Putten's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Van Putten is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Van Putten's licenses on file in 6 states: California, Illinois, Michigan, Indiana, Nevada and West Virginia.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Van Putten treats.

CMS data shows 522 Medicare services from Dr. Van Putten across 13 procedure codes in 2024, for 260 Medicare patients. Medicare paid $72,326 for them.

CMS counts 260 Medicare patients who saw Dr. Van Putten in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Putten's median patient age at 71, with 63% women.

In 2024, Dr. Van Putten wrote 439 Medicare Part D claims for 209 patients. 74% of them were for generic drugs. CMS names the drug for 371 of them, across 10 drugs with 11 or more claims each, at $1,301,724 in total drug cost. In 2023, CMS named 337 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Van Putten for performance year 2024, reported as part of a group. Dr. Van Putten accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of melanoma (skin cancer) excision by Dr. Van Putten, more than 71% of the clinicians it reports for that procedure.

CMS Open Payments shows 210 general payments to Dr. Van Putten from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. Amgen Inc. paid the most, $56,733.

Dmand AI lists 1 award for Dr. Van Putten, most recently CMS Stage 1 EHR in 2013.

Dr. Van Putten graduated from Loma Linda University School Of Medicine in 1985.

Dr. Van Putten is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.